We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 335 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.36% less ownership

Funds ownership: 99.37% → 0.01% (-99%)

100% less funds holding

Funds holding: 343 → 1 (-342)

100% less funds holding in top 10

Funds holding in top 10: 33 → 0 (-33)

100% less capital invested

Capital invested by funds: $10.8B → $236K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 335

Holders
1
Holders Change
-342
Holders Change %
-99.71%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
335
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$927M
2
RCM
RA Capital Management
Massachusetts
-$623M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$501M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$436M
5
PCM
Pentwater Capital Management
Florida
-$435M
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
51
LMR Partners
United Kingdom
– -$43.2M -598,525 Closed
HCM
52
Highbridge Capital Management
New York
– -$42.2M -585,550 Closed
SC
53
Sculptor Capital
New York
– -$40.8M -566,000 Closed
ACM
54
ADAR1 Capital Management
Texas
– -$39.4M -546,534 Closed
Barclays
55
Barclays
United Kingdom
– -$38.3M -531,203 Closed
PAMP
56
Polar Asset Management Partners
Ontario, Canada
– -$38.2M -529,510 Closed
EAM
57
Eventide Asset Management
Massachusetts
– -$37.8M -524,643 Closed
LGM
58
Logos Global Management
California
– -$36.1M -500,000 Closed
Westfield Capital Management
59
Westfield Capital Management
Massachusetts
– -$34M -471,127 Closed
Citigroup
60
Citigroup
New York
– -$33.7M -467,686 Closed
ACM
61
Alethea Capital Management
Washington
– -$32.2M -446,127 Closed
CAU
62
Caxton Associates (UK)
– -$31.9M -442,307 Closed
SSA
63
Schonfeld Strategic Advisors
New York
– -$31.7M -439,812 Closed
PMAM
64
Picton Mahoney Asset Management
Ontario, Canada
– -$30.7M -425,000 Closed
Bank of New York Mellon
65
Bank of New York Mellon
New York
– -$30.1M -417,539 Closed
CM
66
Capula Management
Cayman Islands
– -$28.1M -389,566 Closed
OBAM
67
ODDO BHF Asset Management
France
– -$27.2M -377,500 Closed
TS
68
Twin Securities
New York
– -$26.3M -365,144 Closed
NCM
69
Nearwater Capital Markets
Ireland
– -$26M -360,200 Closed
MAM
70
Melqart Asset Management
United Kingdom
– -$25.7M -355,691 Closed
SGCM
71
Sand Grove Capital Management
United Kingdom
– -$23.9M -331,605 Closed
HM
72
Harvest Management
New York
– -$23.8M -329,300 Closed
GF
73
Gabelli Funds
New York
– -$23.7M -328,616 Closed
BGIM
74
Boussard & Gavaudan Investment Management
United Kingdom
– -$23.7M -328,204 Closed
Allianz Asset Management
75
Allianz Asset Management
Germany
– -$22.4M -309,887 Closed
1 2
3
4 5

RNAM Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2026, worth a combined $236K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 335 funds closed out of RNAM and 0 opened new positions — a net loss of 335 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $927M sold.

  • 1 institutional investor held Avidity Biosciences (RNAM) as of Q1 2026, down from 343 in Q4 2025.
  • Funds reported $236K of Avidity Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avidity Biosciences positions in Q1 2026 and 335 closed out, a net change of -335 holders.
  • The largest Avidity Biosciences seller in Q1 2026 was BlackRock, an estimated $927M sold.

Based on aggregated 13F filings for Q1 2026.